11.1 Flashcards

(10 cards)

1
Q
  1. How is dopamine synthesis exploited to treat Parkinson disease?
A

L-DOPA, the precursor to dopamine, is administered to boost brain dopamine levels, compensating for the loss of dopaminergic neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q
  1. What role do AADC inhibitors play in L-DOPA therapy?
A

AADC inhibitors (e.g., carbidopa, benserazide) block peripheral conversion of L-DOPA to dopamine, allowing more L-DOPA to cross the blood-brain barrier and reducing side-effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q
  1. What are some common side-effects associated with L-DOPA treatment?
A

Side-effects include dyskinesia, motor fluctuations, nausea, orthostatic hypotension, and occasional psychiatric symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. How do dopamine agonists work in Parkinson’s treatment?
A

Dopamine agonists (e.g., pramipexole, ropinirole) directly stimulate dopamine receptors, bypassing the need for dopamine synthesis by surviving neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. What is the function of COMT inhibitors in Parkinson therapy?
A

COMT inhibitors (e.g., entacapone) inhibit the metabolism of L-DOPA, increasing its availability and prolonging its effects in the brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. What other pharmacological treatments are used in Parkinson disease?
A

Additional options include anticholinergics to balance cholinergic overactivity and amantadine, which acts as an NMDA receptor antagonist to reduce dyskinesia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  1. What surgical approach is available for advanced Parkinson disease?
A

Deep brain stimulation (DBS) involves implanting electrodes (commonly in the subthalamic nucleus) to modulate abnormal neural activity and improve motor symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  1. What are the challenges in long-term management of Parkinson disease?
A

Long-term management is challenged by progressive neurodegeneration, emerging motor fluctuations, dyskinesia, non-motor symptoms, and the need for ongoing treatment adjustments.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  1. How does patient and carer engagement enhance management outcomes in Parkinson disease?
A

Active participation in decision making, exercise, nutrition, and symptom monitoring helps optimize treatment, improve quality of life, and better manage both motor and non-motor symptoms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
  1. Why is treatment adjustment necessary over the disease course in Parkinson disease?
A

As the disease progresses and side-effects emerge, treatment regimens need regular modifications to maintain symptom relief while minimizing adverse effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly